Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed.
The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said Thursday.
More than 50 drugs are under development for treating a respiratory disease that is the third-leading cause of death in the United States.
Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.
A possible pill mix-up has prompted Pfizer to recall more than two dozen lots of a prescription contraceptive drug, the drug maker said.
The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.
A former Johnson & Johnson executive has been appointed to serve as interim CEO for Savient Pharmaceuticals.
A goal to standardize risk evaluation and mitigation strategies and modernize the U.S. drug safety system in a proposed reauthorization of the Prescription Drug User Fee Act has drawn support from the country's main chain retail pharmacy lobby.
The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.
Watson Pharmaceuticals is planning to open a global research and development technology center.